NeoStem and ImmuneRegen to Collaborate on Stem Cells
Posted on April 22, 2010 at 02:31 AM EDT
NeoStem, Inc. announced a stem cell collaboration with ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB: IRBS). NeoStem will investigate whether Homspera®, ImmuneRegen’s lead product, will enhance stem cell activity when used in combination with NeoStem's VSEL™ technology. More details... Stock Symbol: (NYSE Amex: NBS)
